11:10 AM EST, 01/28/2025 (MT Newswires) -- Neurocrine Biosciences ( NBIX ) said Tuesday that it started a phase 3 registrational study to evaluate the efficacy, safety, and tolerability of osavampator as an adjunctive treatment to antidepressants for major depressive disorder. The company said the study will enroll adults primarily diagnosed with major depressive disorder and have inadequate response to...

11:07 AM EST, 01/28/2025 (MT Newswires) -- Montero Mining and Exploration ( MXTRF ) on Monday said it finalized the distribution of the US$27 million settlement with its litigation funders, Omni Bridgeway (Canada). The settlement amount was agreed with Tanzania over the expropriation of Montero's Wigu Hill rare earth element project. The company said it has already paid Omni US$12...

11:14 AM EST, 01/28/2025 (MT Newswires) -- Medexus Pharmaceuticals ( MEDXF ) , down 13% on last look, said it priced its overnight marketed underwritten offering of 7.5-million shares at $4.00 each to raise $30 million. The underwriters have been granted an over-allotment option of up to 1.13 million shares. Proceeds will be used to repay a US$2.5 million credit...

11:14 AM EST, 01/28/2025 (MT Newswires) -- Price: 5.82, Change: +0.02, Percent Change: +0.26 ...